Trial intelligence / Profile preview

Post-marketing Study of EV71 Inactivated Vaccine in Children

CTR20190224Phase 4Active

Sponsor
Sinovac Biotech Ltd.
Start
Mar 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of enterovirus 71 vaccine (vero cell), inactivated, sponsored by Sinovac Biotech Ltd.. Started Mar 2019; status: active.

02

Drugs

enterovirus 71 vaccine (vero cell), inactivated

Beyond the preview

Go deeper on CTR20190224.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20190224.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call